Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Letter from the Editor
It seems that we are finally acknowledging that preventing diabetes is an idea that may be worthwhile. This week, we have a feature about how to predict which children will develop diabetes in their lifetime. This gives us an earlier place to start treating prediabetes. We also can start testing sooner and use metformin sooner, as seen in article #2, and we can even make a correlation between bone size and the risk of diabetes if we look soon enough.
Dave Joffe
Editor-in-chief
This Week's Survey
Which new drug class have you seen the best results with in lowering A1c’s?
1) DPP-4
2) GLP-4
3) SGLT-2
4) Other
Follow the link to see what others think!
Newsflash: 3 New Drugs Approved for Reducing Risk of Death
Patient App
Manage diabetes quickly and on the go with LogFrog DB Lite, free for seven days of use! In a few seconds you can track: blood glucose, insulin or oral medication, carb intake, exercise, weight and more! LogFrog DB Lite can help keep you organized and help you analyze and better understand your data.
Test Your Knowledge
True or false? Diabetes increases the risk for conjunctivitis.
Follow the link to see if you got it right!
Did You Know: Glucagon Nasal Powder Easier and More Effective to Use Than Injection
Adult volunteers and caregivers were more successful at using glucagon nasal powder devices than traditional injections to treat a patient with severe hypoglycemia in a simulated situation. The devices are single-use and designed to shoot a dry powder up the nose in rescue situations. The device was safe and effective in children and teens. The results from a phase III trial showed that the powder was as effective as reversing hypoglycemia in adults as injected glucagon and easier to administer.
Yale, J. et al “Needle-free nasal delivery of glucagon is superior to injectable delivery in simulated hypoglycemia rescue” EASD 2015; Abstract #867
U.S. researchers confirm that prediabetes risk, presence can be identified using A1C test with same accuracy as other, less convenient tests.
Object of meta-analysis to assess diagnostic accuracy of screening tests for prediabetes and efficacy of interventions (lifestyle or metformin) in preventing diabetes.
Meta-analysis found metformin therapy was associated with decreased risk for colorectal adenomas and colorectal cancer among T2 patients.
Insulin resistance is inversely and independently associated with bone size in young men without diabetes, according to a new study.
Researchers say sleeping BP may be novel target for diabetes prevention.
CV data added to labels for treatments containing empagliflozin.
Quote of the Week!
“Health is not valued till sickness comes.”
…Thomas Fuller
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com